Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2–4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized <scp>DELIVER</scp> Trial

Cristina Tassorelli, Amaal J. Starling, Susanne F. Awad, Xin Ying Lee, Line Pickering Boserup, Divya Asher, Seema Soni‐Brahmbhatt, Bjørn Sperling, Peter J. Goadsby

Open source

DOI: 10.1111/ene.70460
Published: 2025-12
Container: European Journal of Neurology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ene.70460,
  title = {Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2–4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized
                    <scp>DELIVER</scp>
                    Trial},
  author = {Cristina Tassorelli and Amaal J. Starling and Susanne F. Awad and Xin Ying Lee and Line Pickering Boserup and Divya Asher and Seema Soni‐Brahmbhatt and Bjørn Sperling and Peter J. Goadsby},
  year = {2025},
  journal = {European Journal of Neurology},
  doi = {10.1111/ene.70460},
  url = {https://doi.org/10.1111/ene.70460}
}

RIS

TY  - JOUR
TI  - Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2–4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized
                    <scp>DELIVER</scp>
                    Trial
AU  - Cristina Tassorelli
AU  - Amaal J. Starling
AU  - Susanne F. Awad
AU  - Xin Ying Lee
AU  - Line Pickering Boserup
AU  - Divya Asher
AU  - Seema Soni‐Brahmbhatt
AU  - Bjørn Sperling
AU  - Peter J. Goadsby
PY  - 2025
JO  - European Journal of Neurology
DO  - 10.1111/ene.70460
UR  - https://doi.org/10.1111/ene.70460
ER  -

APA

Tassorelli, C., Starling, A. J., Awad, S. F., Lee, X. Y., Boserup, L. P., Asher, D., Soni‐Brahmbhatt, S., Sperling, B., & Goadsby, P. J. (2025). Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2–4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized <scp>DELIVER</scp> Trial. European Journal of Neurology. https://doi.org/10.1111/ene.70460

Source records

crossref · retrieved 2026-09-26T02:07:55.346Z